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Abstract We report a new family with autosomal dom-
inant epilepsy with auditory features (ADEAF) including
focal cortical dysplasia (FCD) in the proband. We aim to
identify the molecular cause in this family and clarify the
relationship between FCD and ADEAF. A large Iranian
Jewish family including 14 individuals with epileptic sei-
zures was phenotyped including high-resolution 3-T MRI.
We performed linkage analysis and exome sequencing.
LGI1, KANK1 and RELN were Sanger sequenced. Seizure
semiology of 11 individuals was consistent with ADEAF.
The proband underwent surgery for right mesiotemporal
FCD. 3-T MRIs in four individuals were unremarkable.
Linkage analysis revealed peaks on chromosome 9p24
(LOD 2.43) and 10q22–25 (LOD 2.04). A novel
heterozygous LGI1 mutation was identified in all affected
individuals except for the proband indicating a phenocopy.
Exome sequencing did not reveal variants within the
chromosome 9p24 region. Closely located variants in
KANK1 and a RELN variant did not segregate with the
phenotype. We provide detailed description of the pheno-
typic spectrum within a large ADEAF family with a novel
LGI1 mutation that was conspicuously absent in the pro-
band with FCD, demonstrating that despite identical clin-
ical symptoms, phenocopies in ADEAF families may exist.
This family illustrates that rare epilepsy syndromes within
a single family can have both genetic and structural
etiologies.
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Introduction
Autosomal dominant (partial) epilepsy with auditory fea-
tures (ADEAF) is a familial focal epilepsy syndrome with
lateral temporal lobe seizure onset in affected family
members [1]. Characteristic features are auditory auras and
aphasic seizures. Most frequently, simple auditory auras
such as humming, buzzing or ringing are reported by
affected patients. Complex auditory features such as voices
or singing occur less frequently. Affected individuals may
also experience other sensory auras including visual as well
as motor, psychic or autonomic features [1]. Diagnosis of
ADEAF is suspected if C2 family members experience
auditory auras or aphasic seizures [1].
Mutations in the leucine-rich glioma-inactivated 1 gene
(LGI1, Entrez Gene ID 9211, OMIM ID 604619, [1] and,
recently, reelin (RELN, Entrez Gene ID 5649, OMIM ID
600514, [2] were reported in about 35 and 17.5 %,
respectively, of ADEAF families.
Brain imaging is considered unremarkable although in
one LGI1-positive family temporal lobe malformations, in
particular enlargement of the left temporal lobe, were
identified by high-resolution MRI [3]. Furthermore, voxel-
based analyses revealed increased anisotropy in the left
temporal cortex in a group of LGI1-positive ADEAF
patients whose MRI was unremarkable on visual analysis
[4].
Here, we report a new ADEAF family including one
family member who underwent epilepsy surgery due to
right temporal focal cortical dysplasia (FCD). We aim to
clarify if FCD can occur in ADEAF, identify the molecular
cause and provide a description of the phenotypic range
within this family.
Methods
A large Iranian Jewish family with 14 affected individuals
living in Israel was recruited and phenotyped by direct or
telephone interviews except for individual II-5 whose his-
tory was obtained from his daughter III-9 (Fig. 1). Avail-
able medical records were obtained. Routine EEG studies
and high-resolution structural 3-T MRI data were collected
using a 3-T scanner (Achieva magnet; Philips Healthcare)
on the individuals III-12, III-15, III-17 and IV-13 who had
consented to these additional studies. A routine epilepsy
protocol was used including pre- and post-contrast anatomy
scans (T1W, TE/TR = 3.7/8.2 ms, acquisition matrix
432*432, voxel size: 0.5*0.5*1 mm), FLAIR (Axial, TE/
TR = 125/11,000 ms, IR = 2800, acquisition matrix:
272*195, voxel size: 0.5*0.5*5 mm), DTI (16 directions,
voxel size 2 9 2 9 2 mm; 50 slices; matrix 116 9 114;
TE = 86 ms, TR = 6.784 s), and T2-weighted (voxel
size 0.47 9 0.59 9 4 mm; 30 slices; matrix 488 9 292;
TE = 90 ms, TR = 3 s). The slices were orientated per-
pendicular or parallel to the long axis of the hippocampus.
DNA was extracted from peripheral blood samples.
Genotyping was performed using Illumina OmniEx-
pressExome single nucleotide polymorphism genotyping
microarrays in 15 family members. Error checking verified
the accuracy of the pedigree and indicated high-quality
genotyping information. After removing Mendelian and
Fig. 1 Pedigree of the family showing segregation of the LGI1 mutation and KANK1 variant. The arrow indicates the proband. LGI1 leucine-
rich, glioma-inactivated 1 gene, KANK1 KN motif and ankyrin repeat domains 1 gene, RELN reelin gene, m mutation/variant present, – wild type
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double recombinant errors, 6312 single nucleotide poly-
morphism markers were selected for linkage analysis.
Exact parametric multipoint linkage analysis was calcu-
lated with MERLIN [5]. According to previous reports in
ADEAF [6] penetrance was set to 0.7. A phenocopy rate of
0.01 was used reflecting the prevalence of epilepsy in the
population. Disease allele frequency was set to 0.0001 as
the disease allele was assumed to be rare in the population.
Sanger sequencing of all exons of LGI1 was performed
in individuals III-11 and III-17. Exon 6 was Sanger
sequenced in all 15 available family members.
Exome sequencing was performed in individual III-17
using the Illumina HiSeq platform. Segregation analysis of
a KN motif and ankyrin repeat domains 1 (KANK1, Entrez
Gene ID 23189, OMIM ID 607704) and a RELN variant
was performed by Sanger sequencing in all 15 available
family members.
Results
The family included 14 individuals with a history of
seizures over three generations. Phenotypic information
was available in 11 individuals including the deceased
individual II-7 whose history was obtained from his wife
and children. Seizure semiology of these 11 individuals
was consistent with ADEAF. Median seizure onset was at
15 years. Four family members reported auditory auras,
two visual auras and the proband described vertiginous
auras (Table 1). Focal dyscognitive seizures with altered
awareness or responsiveness occurred in five individuals
including two (III-19, IV-13) who reported that they were
unable to talk but could understand other people. Indi-
vidual III-17 reported that he was unable to hear and
individuals III-11 and IV-21 had loss of awareness during
the focal dyscognitive seizures. Evolution to bilateral
convulsive seizures (previously secondarily generalized
tonic–clonic seizures) occurred in seven individuals.
Three additional family members only had bilateral
convulsive seizures without focal features. In four indi-
viduals bilateral convulsive seizures occurred exclusively
(III-19, IV-19) or predominantly (III-15, IV-13) during
sleep. The occurrence of seizures was reported in three
further family members but no details were available.
Two of these were deceased. Electroencephalographic
studies in individuals III-12, III-15, III-17 and IV-13 did
not show epileptiform discharges. EEGs done for clinical
reasons in individuals III-9, III-19, IV-21 were
unremarkable.
Magnetic resonance imaging in the proband IV-21
revealed a right mesiotemporal tumor, which was consid-
ered most consistent with a low grade glioma (Fig. 2). The
proband underwent surgery and pathology revealed FCD
type IIA. Brain MRI in individual III-19 revealed a
meningioma in the cerebellopontine angle but no epilep-
togenic lesion. High-resolution structural 3T-MRIs in
individuals III-12, III-15, III-17 and IV-13 were
unremarkable.
Epilepsy was mild in most individuals. Five family
members became seizure free on medication or had only
infrequent seizures when discontinuing medication. Only
three individuals continued to have seizures despite taking
medication. The proband IV-21 became seizure free after
surgery.
Linkage analysis categorizing the proband IV-21 as
having unknown affected status revealed peaks (Online
Resource 1, 2) on chromosome 9p24 (LOD score 2.43) and
10q22–25 (LOD score 2.04). The latter included LGI1.
Sanger sequencing of LGI1 revealed a heterozygous
mutation in exon 6 (c.641T[C, p.214L[P, NM_005097,
Online Resource 3) which was predicted to be deleterious by
SIFT (score 0) [7] and probably damaging by PolyPhen-2
(score 0.953) [8]. The mutation affects the leucine-rich repeat
C-terminal domain by changing an acyclic to a heterocyclic
amino acid at a conserved site. The mutation was present in all
affected family members except for the proband and has not
been reported previously as a pathogenic mutation nor as
benign polymorphism in the ExAC database (Exome Aggre-
gation Consortium (ExAC), Cambridge, MA, USA (URL:
http://exac.broadinstitute.org) [accessed June 2015]).
Exome sequencing was performed in individual III-17.
After filtering for exonic or splice site variants with a fre-
quency\1 % in the Exome Variant Server (ESP6500_all)
and 1000 Genomes (1000 g2012apr, [9] databases and after
excluding synonymous variants and segmental duplications,
720 variants remained. None of these variants were located
within the linkage region on chromosome 9p24. One variant
in exon 9 of KANK1 (c.3296G[C, p. 1099G[A,
NM_153186) was located 161 kb upstream of the linkage
region and did not segregate with the phenotype (Fig. 1).
Eleven variants in 10 genes were located within the linkage
region on chromosome 10q22–25 including the LGI1
mutation. None of the other 9 genes were considered a likely
candidate gene for ADEAF. A variant in exon 45 of RELN
(c.7114G[A, p.2372V[M, rs114344654, NM_005045)
with a frequency of 22/121246 (0.0001814) in the ExAC
database did not segregate with the phenotype (Fig. 1).
Discussion
Seizure semiology reported by the affected members of this
large family was consistent with ADEAF. Four family
members reported the typical auditory auras. Visual auras,
focal dyscognitive seizures and bilateral convulsive sei-
zures were present as well. The majority of family











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































14 J Neurol (2016) 263:11–16
123
members had infrequent and pharmaco-responsive seizures
as is typical for this epilepsy syndrome. EEG studies per-
formed within the framework of our study did not show
epileptiform discharges. Although up to two-thirds of
individuals with ADEAF may show epileptiform dis-
charges [1] other studies have found similarly low fre-
quencies [10].
The remarkable finding in our family was the presence
of right temporal FCD type IIA in the proband. This finding
initially raised the question if FCD may be part of the
phenotypic spectrum of ADEAF considering two previous
reports on temporal lobe abnormalities in ADEAF families
[3, 4]. Furthermore, FCD has recently been reported in
familial focal epilepsy with variable foci [11] which is a
related focal epilepsy syndrome caused by mutations in
DEPDC5 [12]. The proband did not experience auditory
auras or aphasic seizures but reported vertiginous auras
which also have been described in ADEAF families [13].
However, as most families with ADEAF have not been
reported to show MRI abnormalities, the proband was
considered to have unknown affected status for the linkage
analysis which revealed that he did not carry the chromo-
some 10 haplotype. Subsequently, sequencing of LGI1
revealed a novel LGI1 mutation in the family but not in the
proband. The epilepsy phenotype of the proband, therefore,
represents a phenocopy as his epilepsy cannot be attributed
to the familial genomic LGI1 mutation. He is likely to have
a non-genetic cause of his epilepsy although we cannot
exclude the presence of somatic mutations in different
genes. Vestibular sensations have been reported during
stimulation of the insular, lateral temporal, parietal and
frontal cortex [14, 15]. Propagation of the ictal activity to
one of these regions is the likely explanation for the
occurrence of a vertiginous aura in the proband resulting in
a similar seizure semiology as can be observed in indi-
viduals with ADEAF.
In addition to the peak on chromosome 10, which
includes the LGI1 mutation, linkage analysis revealed
another peak on chromosome 9. To clarify whether an
identifiable modifier gene may be located within the link-
age region on chromosome 9 we performed exome
sequencing in one affected individual. No variants were
found within the linkage region after filtering but a variant
in KANK1 was located very close to the upper boundary.
The haplotype at this position was shared by all affected
individuals except for III-11. As KANK1 had been reported
in families with congenital cerebral palsy, hypotonia,
quadriplegia and intellectual disability [16, 17], KANK1
was considered a plausible candidate modifier gene.
However, sequencing of this variant in the other family
members revealed that it did not segregate with the
phenotype.
Exome sequencing revealed a rare variant in RELN, a
gene which has recently been reported in ADEAF [2].
However, incomplete segregation (Fig. 1) and the presence
of the variant in controls did not support pathogenicity of
this variant. Nevertheless, a modifying effect in the main
branch of the family cannot be excluded.
In conclusion, we report a new ADEAF family due to a
novel LGI1 mutation, reinforcing the combination of typ-
ical phenotypic features including auditory and visual auras
in combination with a usually mild epilepsy, which con-
stitutes the ADEAF spectrum. The proband’s phenotype
with FCD represents a phenocopy, suggesting that two rare
epilepsy syndromes due to both genetic and structural
causes can coexist within a single family. Our results do
not support that FCD is part of the ADEAF spectrum, in
contrast to other familial focal epilepsy syndromes. Given
Fig. 2 MRI of the proband
showing the right
mesiotemporal lesion. a Coronal
T2-weighted image, b axial
FLAIR image
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that the individual with the phenocopy represented the
initial proband for the analysis of the family, our family is
an instructive example on how candidate genes for a
familial condition may be missed due to phenocopies.
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